Jazz Pharmaceuticals (JAZZ) Gross Margin Growth (3y) (2013 - 2026)

Jazz Pharmaceuticals (JAZZ) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -230.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -168.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 193,280.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 589.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 6.06 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 53.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 569.00
10 Jazz Pharmaceuticals 15.90 Bn 14.28 Bn 1.09 Bn 56.00

Historic Data

Download Data
DateValue
Jun 30, 2026 56.00
Mar 31, 2026 186.00
Dec 31, 2025 440.00
Sep 30, 2025 276.00
Jun 30, 2025 220.00
Mar 31, 2025 252.00
Dec 31, 2024 335.00
Sep 30, 2024 675.00
Jun 30, 2024 512.00
Mar 31, 2024 -397.00
Dec 31, 2023 -306.00
Sep 30, 2023 -285.00
Jun 30, 2023 -446.00
Mar 31, 2023 -820.00
Dec 31, 2022 -1,114.00
Sep 30, 2022 -737.00
Jun 30, 2022 -613.00
Mar 31, 2022 -662.00
Dec 31, 2021 -966.00
Sep 30, 2021 -1,078.00